What Challenges Exist in Targeting Internal Pumps?
While targeting internal pumps presents a promising therapeutic avenue, several challenges remain. One major issue is the potential for toxicity and side effects, as these pumps are also vital for normal cell function. Additionally, cancer cells can develop resistance to pump inhibitors, similar to how they become resistant to chemotherapeutic drugs, necessitating continuous research and development of novel inhibitors.
